Cipla Limited (NSE: CIPLA)
India
· Delayed Price · Currency is INR | Market Cap | 1.19T |
| Revenue (ttm) | 262.64B |
| Net Income (ttm) | 44.75B |
| Shares Out | 807.61M |
| EPS (ttm) | 55.38 |
| PE Ratio | 26.58 |
| Forward PE | 25.04 |
| Dividend | 13.00 (0.88%) |
| Ex-Dividend Date | Aug 2, 2024 |
| Volume | 2,196,863 |
| Open | 1,506.55 |
| Previous Close | 1,506.55 |
| Day's Range | 1,469.05 - 1,506.60 |
| 52-Week Range | 1,221.65 - 1,702.05 |
| Beta | 0.34 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jan 28, 2025 |
About Cipla
Cipla Limited, together with its subsidiaries, engages in the manufacture, development, sale, and distribution of pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New Ventures segments. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney failure, Alzheimer’s disease, hypertension, arrhythmia, lipid abnormaliti... [Read more]
Financial Performance
In 2023, Cipla's revenue was 255.37 billion, an increase of 13.20% compared to the previous year's 225.59 billion. Earnings were 41.22 billion, an increase of 47.10%.
Financial StatementsNews
Nifty 50 top gainers this week: Dr. Reddy’s Laboratories and Cipla shine amid market turmoil
The Indian equity benchmarks, Nifty 50 and Sensex, experienced their sharpest decline in four months on Friday, December 20. The Sensex tumbled 1,176 points, closing at 78,042, while the Nifty 50 drop...
Nifty 50 top gainers today on December 19: Dr. Reddy’s Laboratories, Cipla, Bharat Petroleum and more
Indian benchmark indices continued their downward trend on December 19, marking the fourth consecutive session of losses. At the close, the Sensex dropped by 964.15 points (1.20%) to 79,218.05, while ...
Nifty 50 top gainers today on December 18: Trent, Dr. Reddy’s Laboratories, Cipla and more
On December 18, Indian benchmark indices faced a decline for the third consecutive session, with the Nifty closing below the crucial 24,200 mark. The BSE Sensex fell by 502.25 points, or 0.62%, settli...
Cipla shares surge after Kotak upgrades stock to Buy from Add, target price at Rs 1,725
Cipla’s shares surged 2% after Kotak upgraded the stock to “Buy” from “Add,” with a target price of Rs 1,725, slightly down from the previous Rs 1,750. Despite the anticipated delay in the launch of g...
Pharma Sector Stocks: Torrent Pharma (+0.25%) rises; Glenmark (-2.29%), Aurobindo (-2.02%) decline
The pharma sector showed mixed trends during the session as of 12:15 AM. Torrent Pharma was the only gainer, rising ₹8.45 to ₹3,336.30 (+0.25%). Sun Pharma dipped ₹4.95 to ₹1,800.50 (-0.27%), and Dr. ...
HSBC on Indian Pharma Sector: Strong 2025 Outlook for Cipla, Sun Pharma, and Torrent Pharma
HSBC retains a positive view on Indian pharmaceutical companies, projecting strong performance in 2025 led by peak gRevlimid sales and differentiated launches in the US. Companies under HSBC’s coverag...
Stock market news: Cipla, HDFC Life Insurance and Hero MotoCorp among Nifty 50 top losers this week
As the Indian stock market ended a week of volatile trading on December 6, 2024, major indices saw slight declines. The Sensex closed down by 56.74 points, or 0.07%, while the Nifty dropped by 30.60 p...
Nifty 50 top losers today on December 6: Adani Ports, Cipla, Bharti Airtel and more
On December 6, the Indian equity markets ended on a slightly negative note, with both major indices—the Sensex and Nifty—closing marginally lower following a volatile trading session. The Sensex fell ...
Nifty 50 top losers today on December 4: Bharti Airtel, Cipla, Bajaj Auto and more
On December 4, 2024, Indian equity markets maintained their positive momentum, marking the fourth consecutive day of gains. Both the BSE Sensex and NSE Nifty experienced modest but steady increases. T...
Pharma Stocks: Cipla down nearly 2%, Ajanta Pharma down 1.45%, Abbott India up 1.27%
The Nifty Pharma index was trading 0.25% lower at 22,389.10 during today’s session, as losses in Cipla, Biocon, and Aurobindo Pharma weighed on the sector, despite gains in Abbott India and Ajanta Pha...
Nifty 50 top losers today on December 2: HDFC Life Insurance, Cipla, NTPC and more
On December 2, Indian equity markets ended on a strong note, with both the Nifty 50 and Sensex showing impressive gains. The Sensex surged by 445.29 points, or 0.59%, closing at 80,248.08. Meanwhile, ...
Cipla Block Deal: 1.4 crore shares or 1.72% equity changes hands; stock in focus today
Cipla saw a significant pre-market block deal where 1.39 crore shares, representing 1.72% of the company’s equity, changed hands. The block deal comes amid heightened investor interest in the stock. T...
Stocks to watch today: Maruti Suzuki, TVS Motor, Biocon, DLF, RVNL, RBL, Cipla, Home First, Cochin Shipyard in focus
The stock market is abuzz with updates across several companies today. Below are the highlights in the green and red zones: Maruti Suzuki: November sales saw a minor beat, driven by a strong performan...
Cipla Block Deal: Promoters to sell 1.7% stake worth Rs 2,000 crore via block deal on Monday
According to a report by CNBC Awaaz, citing sources, the promoters of Cipla Limited are set to divest approximately ₹2,000 crore worth of shares through a block deal
Nifty 50 top gainers today on 29 November: Bharti Airtel, Sun Pharmaceutical and Cipla lead the rally
On November 29, 2024, Indian equity indices made a robust comeback, erasing losses from the previous session and closing on a high note. The Nifty 50 surged past the 24,100 mark, while the Sensex rose...
Cipla market cap rises Rs 3,776 crore
Cipla witnessed a significant gain in its stock price, rising 3.13% to Rs 1,539.40 during today’s trading session. This rally added Rs 3,776 crore to the company’s market capitalization, now valued at...
Pharma stocks: Sun Pharma up 1.27%, Dr. Reddy’s rises 0.82%, Cipla gains 0.53%
The pharmaceutical sector saw broad-based gains in early trade on November 29, 2024, with Cipla and Sun Pharma leading the charge. Here’s a detailed look at the top pharma stocks as of 10:34 AM: Stock...
Stocks to watch on November 21, 2024: Nestle, UPL, Cipla, Adani Group, Vedanta and more
Amid mixed global cues, GIFT Nifty futures edged higher indicating a positive start for the Indian markets. In the previous session, the BSE Sensex gained 239.37 points to close at 77,578.38, while th...
Stock to Watch: Cipla faces USFDA observations at Bengaluru manufacturing unit
Cipla Ltd announced that the US Food and Drug Administration (USFDA) has issued eight observations following an inspection of its manufacturing facility in Virgonagar, Bengaluru. The inspection was co...
Cipla Share Price: Nomura upgrades Cipla to buy with 15% upside, sets target price at Rs 1,800
Nomura has upgraded Cipla to a “Buy” rating, establishing a target price of ₹1,800, reflecting a 15% potential upside from the current market price (CMP) of ₹1,560. The brokerage highlights Cipla’s fa...
Morning Gainers Today: Rainbow Children’s, Cipla, L&T, Anant Raj, and Kaynes Tech among top gainers as stocks rally
Here are some of the top gainers on the NSE this morning: Rainbow Children’s Medicare Ltd (RAINBOW) Price: ₹1,622.30 Change: +₹142.10 (+9.60%) Cipla Ltd (CIPLA) Price: ₹1,535.30 Change: +₹117.05 (+8.2...
Cipla hits upper circuit on open, rises 10% after strong Q2 results and mixed brokerage outlook
Cipla’s stock opened at ₹1,560.05 (10% UC) on the NSE and reached an early high of ₹1,560.05 before dipping to a low of ₹1,520.00. Currently trading at ₹1,529.30, the stock is up 7.83% from its previo...
Nifty 50 top losers today on 30 October: Cipla, Shriram Finance, SBI Life Insurance Company and more
The Nifty 50 benchmark index ended lower on Wednesday, driven by renewed selling from foreign portfolio investors (FPIs) and poor earnings reports from some of India’s blue-chip companies. The Nifty 5...
Morning Top Losers: Cipla, MCX India, Dixon Technologies, and more
Here’s a look at some of the top losers in the market this morning as stocks like Cipla, MCX India, and Dixon Technologies faced declines. Cipla led the losses with a drop of nearly 3.85% as of the la...
Stock to watch: Cipla drops 4.62% on weak Q2, brokerage reactions remain mixed
Cipla’s stock opened at ₹1,440.00, declining 4.62% from the previous close of ₹1,477.55, with a low of ₹1,407.20 so far today. Here’s a summary of brokerage reactions: Nomura: Maintained a Neutral rat...